Health Care [ 4/12 ] | Life Sciences Tools & Services [ 51/75 ]
NASDAQ | Common Stock
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms.
The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers.
It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers.
The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients.
The company was founded in 2008 and is headquartered in Irving, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 26, 26 | 0.28 Decreased by -90.07% | 0.10 Increased by +180.00% |
| Nov 5, 25 | 0.08 Decreased by -96.08% | -0.14 Increased by +157.14% |
| Aug 12, 25 | -1.11 Decreased by -160.00% | -0.22 Decreased by -404.55% |
| May 28, 25 | -0.35 Decreased by -119.89% | - |
| Nov 5, 21 | 2.82 Increased by +171.15% | 1.94 Increased by +45.36% |
| Aug 3, 21 | 2.04 Increased by +151.63% | 1.78 Increased by +14.61% |
| Apr 29, 21 | 1.85 Increased by +176.12% | 1.66 Increased by +11.45% |
| Feb 16, 21 | 1.76 Increased by +225.93% | 1.13 Increased by +55.30% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 292.89 M Increased by +192.74% | 81.96 M Increased by +223.83% | Increased by +27.98% Increased by +142.30% |
| Sep 30, 25 | 216.83 M Increased by +168.77% | 24.32 M Increased by +121.91% | Increased by +11.22% Increased by +108.15% |
| Jun 30, 25 | 181.40 M Increased by +79.91% | -71.79 M Decreased by -240.34% | Decreased by -39.58% Decreased by -178.00% |
| Mar 31, 25 | 120.92 M Increased by +41.10% | -102.58 M Decreased by -370.36% | Decreased by -84.84% Decreased by -291.61% |
| Jun 30, 24 | 100.05 M Increased by +23.82% | -66.19 M Decreased by -285.19% | Decreased by -66.15% Decreased by -249.56% |
| Mar 31, 24 | 80.68 M Increased by +25.43% | -111.03 M Decreased by -879.36% | Decreased by -137.62% Decreased by -721.35% |
| Sep 30, 21 | 100.83 M Increased by +27.55% | 51.16 M Increased by +231.25% | Increased by +50.74% Increased by +159.71% |
| Jun 30, 21 | 85.69 M Increased by +13.17% | 37.94 M Increased by +6.16 K% | Increased by +44.28% Increased by +5.46 K% |